Cardinal Health

Medtech M&A: The 10 biggest deals so far in 2017
Medtech M&A: The 10 biggest deals so far in 2017
Mass Device
devices
M&A
Abbott Labs
St. Jude Medical
Edwards Lifesciences
Valtech Cardio
Hologic
Cynosure
JNJ
Teleflex
Vascular Soltions
Cardinal Health
Medtronic
Becton Dickinson
CR Bard
Boston Scientific
Symetis
Integra LifeSciences
Codman Neuro
Stryker
Novadaq
Flag link:
Cardinal Health quarterly profit ahead of estimates
Cardinal Health quarterly profit ahead of estimates
Yahoo/Reuters
earnings
Cardinal Health
devices
Flag link:
Cardinal Health buying medical supplies business from Medtronic for $6.1 billion
Cardinal Health buying medical supplies business from Medtronic for $6.1 billion
Bizjournals.com
Cardinal Health
devices
medical supplies
Medtronic
M&A
Flag link:
Medtronic Stock Gaining on Reported Deal to Sell Medical Supplies Unit
Medtronic Stock Gaining on Reported Deal to Sell Medical Supplies Unit
TheStreet.com
Medtronic
M&A
medical supplies
Cardinal Health
Flag link:
Navidea stock jumps 76% after agreeing to $80 million Cardinal Health deal
Navidea stock jumps 76% after agreeing to $80 million Cardinal Health deal
Marketwatch
Navidea Biopharmaceuticals
Cardinal Health
Lymphoseek
M&A
Flag link:
Johnson & Johnson Cordis Sale Finalized
Johnson & Johnson Cordis Sale Finalized
Investopedia
JNJ
Cardinal Health
Cordis
M&A
Flag link:
Cardinal Health to buy NaviHealth for $410m
Cardinal Health to buy NaviHealth for $410m
Mass Device
Cardinal Health
NaviHealth
M&A
Flag link:
Cardinal to Buy Harvard Drug Group for $1.12 Billion
Cardinal to Buy Harvard Drug Group for $1.12 Billion
Bloomberg
Cardinal Health
M&A
Harvard Drug Group
generics
Flag link:
J&J accepts offer from Cardinal Health for Cordis unit
J&J accepts offer from Cardinal Health for Cordis unit
Yahoo/AP
JNJ
Cardinal Health
Cordis
devices
M&A
Flag link:
Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis
Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis
Yahoo
JNJ
Cardinal Health
Cordis
M&A
Flag link:
Johnson & Johnson reportedly in talks to sell its Cordis unit; Cardinal Health is rumored to be the leading bidder
Johnson & Johnson reportedly in talks to sell its Cordis unit; Cardinal Health is rumored to be the leading bidder
Bidness Etc.
JNJ
Cordis
devices
M&A
Cardinal Health
Flag link:
Hot Stock Industry Group: Drug Distributors Ride High
Hot Stock Industry Group: Drug Distributors Ride High
Investors.com
AmerisourceBergen
McKesson
Cardinal Health
MWI Veterinary Supply
Flag link:
Will ObamaCare Help McKesson, Other Drug Companies?
Will ObamaCare Help McKesson, Other Drug Companies?
Investors.com
Affordable Care Act
McKesson
AmerisourceBergen
Cardinal Health
Flag link:
Drug buyers sue Novo Nordisk over 'wrongful' delays to diabetes generic
Drug buyers sue Novo Nordisk over 'wrongful' delays to diabetes generic
Fierce Pharma
pay-for-delay
Novo Nordisk
generics
diabetes
Cardinal Health
Flag link:
CVS, Cardinal Health To Start Generic Drug Supplier
CVS, Cardinal Health To Start Generic Drug Supplier
Bloomberg
Cardinal Health
generics
CVS
Flag link:
Johnson & Johnson, Cardinal Health Win Pentagon Contracts
Johnson & Johnson, Cardinal Health Win Pentagon Contracts
Motley Fool
Cardinal Health
JNJ
government contracts
Flag link:
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Vertex Pharmaceuticals
Pharmacyclics
Novartis
Celsion
Peregrine Pharmaceuticals
Prana
Navidea Biopharmaceuticals
Cardinal Health
ONYX Pharmaceuticals
Bayer
Sarepta
Hyperion Therapeutics
Amarin
Medivation
Astellas
JNJ
Trius
Sangamo BioSciences
Flag link:
Companies That Can Mend The Biotech Market: Stephen Brozak
Companies That Can Mend The Biotech Market: Stephen Brozak
Seeking Alpha
Trius Therapeutics
NuPathe
Navidea Biopharmaceuticals
Cytori
Cempra
Cardinal Health
BioTime
Alexza Pharmaceuticals
Aastrom Biosciences
Flag link:
Cardinal Health Agrees to Buy AssuraMed for $2.07 Billion
Cardinal Health Agrees to Buy AssuraMed for $2.07 Billion
Bloomberg
AssuraMed
Cardinal Health
M&A
Flag link:
China Biotech In Review: Cardinal Health Uses M&A To Add Drug Distribution Reach
China Biotech In Review: Cardinal Health Uses M&A To Add Drug Distribution Reach
Seeking Alpha
Cardinal Health
M&A
3SBio
Neusoft
Zhejiang Hisun Pharma
Grandhope Biotech
CVie Therapeutics
Solasia
Flag link: